Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Katayoon Kasaian
Affiliation
Ontario Institute for Cancer Research
ORCID
Career Start Year
2008
Papers
30
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
30514790
Clinical outcomes after whole-genome sequencing in patients with metastatic non-small-cell lung cancer.
Cold Spring Harb Mol Case Stud
2019
30514790
Clinical outcomes after whole-genome sequencing in patients with metastatic non-small-cell lung cancer.
Cold Spring Harb Mol Case Stud
2019
30988300
PDGFRα<sup>+</sup> stromal adipocyte progenitors transition into epithelial cells during lobulo-alveologenesis in the murine mammary gland.
Nat Commun
2019
30988300
PDGFRα<sup>+</sup> stromal adipocyte progenitors transition into epithelial cells during lobulo-alveologenesis in the murine mammary gland.
Nat Commun
2019
29898407
Integrated Molecular Characterization of Testicular Germ Cell Tumors.
Cell Rep
2018
32832832
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.
JCO Precis Oncol
2018
30049282
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Acta Neuropathol Commun
2018
29898407
Integrated Molecular Characterization of Testicular Germ Cell Tumors.
Cell Rep
2018
32832832
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.
JCO Precis Oncol
2018
30049282
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Acta Neuropathol Commun
2018
27872141
Differential roles of RET isoforms in medullary and papillary thyroid carcinomas.
Endocr Relat Cancer
2017
28860053
Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.
Transl Res
2017
28680294
Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy.
Curr Oncol
2017
28808080
Characterization of the human thyroid epigenome.
J Endocrinol
2017
29872713
Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event.
NPJ Precis Oncol
2017
29246904
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer.
Clin Cancer Res
2017
27872141
Differential roles of RET isoforms in medullary and papillary thyroid carcinomas.
Endocr Relat Cancer
2017
29872713
Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event.
NPJ Precis Oncol
2017
29246904
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer.
Clin Cancer Res
2017
28808080
Characterization of the human thyroid epigenome.
J Endocrinol
2017
28860053
Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.
Transl Res
2017
28680294
Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy.
Curr Oncol
2017
27148585
Putative BRAF activating fusion in a medullary thyroid cancer.
Cold Spring Harb Mol Case Stud
2016
27240287
Clinical importance of bilateral disease in patients with papillary thyroid cancer.
Can J Surg
2016
27148585
Putative BRAF activating fusion in a medullary thyroid cancer.
Cold Spring Harb Mol Case Stud
2016
26578589
ORegAnno 3.0: a community-driven resource for curated regulatory annotation.
Nucleic Acids Res
2016
26536169
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
N Engl J Med
2016
27604489
Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney.
Cancer Discov
2016
28050146
Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study.
Curr Oncol
2016
26536169
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
N Engl J Med
2016
26578589
ORegAnno 3.0: a community-driven resource for curated regulatory annotation.
Nucleic Acids Res
2016
28050146
Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study.
Curr Oncol
2016
27604489
Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney.
Cancer Discov
2016
27240287
Clinical importance of bilateral disease in patients with papillary thyroid cancer.
Can J Surg
2016
25625803
MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.
J Clin Endocrinol Metab
2015
25625803
MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.
J Clin Endocrinol Metab
2015
25656989
Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.
BMC Cancer
2015
27148575
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers.
Cold Spring Harb Mol Case Stud
2015
26061751
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
N Engl J Med
2015
25997714
Papillary thyroid carcinoma: prognostic significance of cancer presentation.
Am J Surg
2015
26680454
The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
BMC Cancer
2015
27148575
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers.
Cold Spring Harb Mol Case Stud
2015
26680454
The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
BMC Cancer
2015
26061751
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
N Engl J Med
2015
25997714
Papillary thyroid carcinoma: prognostic significance of cancer presentation.
Am J Surg
2015
25656989
Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.
BMC Cancer
2015
24807916
Diagnostic value of next-generation sequencing in an unusual sphenoid tumor.
Oncologist
2014
24807916
Diagnostic value of next-generation sequencing in an unusual sphenoid tumor.
Oncologist
2014
23616356
Complete genomic landscape of a recurring sporadic parathyroid carcinoma.
J Pathol
2013
23616356
Complete genomic landscape of a recurring sporadic parathyroid carcinoma.
J Pathol
2013
1 - 50 of 60
Column Actions
Search
Recommended Authors
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year
2016
Number of shared co-authors
3
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year
2014
Number of shared co-authors
6
Maxime Tarabichi
ULB-Cancer Research Center (U-CRC), Universite Libre de Bruxelles
Career Start Year
2012
Number of shared co-authors
3
Myriem Boufraqech
The University of Texas at Austin
Career Start Year
2010
Number of shared co-authors
3
Jack Zhu
Center for Cancer Research, National Cancer Institute Bethesda
Career Start Year
2010
Number of shared co-authors
0
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year
2010
Number of shared co-authors
15
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Career Start Year
2009
Number of shared co-authors
6
Charlotte K Y Ng
University of Bern
Career Start Year
2009
Number of shared co-authors
11
Salvatore Piscuoglio
University of Basel
Career Start Year
2008
Number of shared co-authors
8
Cyriac Kandoth
University of California los angeles
Career Start Year
2008
Number of shared co-authors
61
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2007
Number of shared co-authors
0
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
22
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
6
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
6
Rebecca Nagy
Guardant Health Inc.
Career Start Year
2004
Number of shared co-authors
4
Sherri Z Millis
Foundation Medicine Inc
Career Start Year
2003
Number of shared co-authors
1
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
42
Sandya Liyanarachchi
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Career Start Year
2002
Number of shared co-authors
0
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year
2002
Number of shared co-authors
21
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2001
Number of shared co-authors
0
Luciano G Martelotto
Monash University
Career Start Year
2000
Number of shared co-authors
4
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year
2000
Number of shared co-authors
26
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
79
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year
1997
Number of shared co-authors
12
Siraj M Ali
Foundation Medicine
Career Start Year
1995
Number of shared co-authors
8
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year
1993
Number of shared co-authors
12
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
40
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year
1991
Number of shared co-authors
48
Nallasivam Palanisamy
Vattikuti Urology Institute
Career Start Year
1990
Number of shared co-authors
13
Thomas J Giordano
University of Michigan ann arbor
Career Start Year
1989
Number of shared co-authors
55
row(s) 1 - 30 of 30
Collaborators
Steven J M Jones
University of British Columbia
Co-authored papers
21
Marco A Marra
University of British Columbia
Co-authored papers
13
Richard A Moore
Co-authored papers
11
Andrew J Mungall
Co-authored papers
11
Jacqueline E Schein
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers
9
Janessa Laskin
Co-authored papers
6
Yussanne Ma
Co-authored papers
5
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers
5
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers
5
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers
4
Rajen Mody
Co-authored papers
4
Carl Koschmann
University of Michigan-Ann Arbor
Co-authored papers
4
Nina Thiessen
Co-authored papers
4
Sriram Venneti
Co-authored papers
4
Martin R Jones
BC Cancer Research Centre.
Co-authored papers
4
David G Huntsman
University of British Columbia
Co-authored papers
4
Angela Tam
Co-authored papers
4
Xuhong Cao
Michigan Center for Translational Pathology.
Co-authored papers
4
Martin Hirst
University of British Columbia
Co-authored papers
4
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers
3
Carolyn M Hutter
National Human Genome Research Institute, National Institutes of Health
Co-authored papers
3
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers
3
Reanne Bowlby
Co-authored papers
3
Kristen Leraas
Nationwide Children's Hospital
Co-authored papers
3
Chandan Kumar-Sinha
Co-authored papers
3
Cheryl Ho
University of British Columbia
Co-authored papers
3
Hugh J L Garton
Co-authored papers
3
Jean Claude Zenklusen
National Cancer Institute
Co-authored papers
3
Obi L Griffith
Washington University
Co-authored papers
3
Matthew Meyerson
Broad Institute
Co-authored papers
3
1 - 30